首页> American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons> Cyclosporine Does Not Prevent Microvascular Loss in Transplantation but Can Synergize With a Neutrophil Elastase Inhibitor, Elafin, to Maintain Graft Perfusion During Acute Rejection.

Cyclosporine Does Not Prevent Microvascular Loss in Transplantation but Can Synergize With a Neutrophil Elastase Inhibitor, Elafin, to Maintain Graft Perfusion During Acute Rejection.

导出 OA

翻译打印收藏纠错

第一作者： X,Jiang

第一单位： Veterans Affairs Palo Alto Health Care System, Medical Service, Palo Alto, CA.;Department of Medicine, Division of Pulmonary and Critical Care Medicine, Stanford University School of Medicine, Stanford, CA.

作者： X,Jiang ^[1] ; T T,Nguyen ^[1] ; W,Tian ^[1] ; Y K,Sung ^[1] ; K,Yuan ^[2] ; J,Qian ^[1] ; J,Rajadas ^[3] ; J-M,Sallenave ^[4] ; N P,Nickel ^[5] ; V,de Jesus Perez ^[2] ; M,Rabinovitch ^[5] ; M R,Nicolls ^[1]

作者单位： Veterans Affairs Palo Alto Health Care System, Medical Service, Palo Alto, CA.;Department of Medicine, Division of Pulmonary and Critical Care Medicine, Stanford University School of Medicine, Stanford, CA. ^[1] Department of Medicine, Division of Pulmonary and Critical Care Medicine, Stanford University School of Medicine, Stanford, CA. ^[2] Stanford BioADD Laboratory, Stanford, CA. ^[3] Unité de Défense Innée et Inflammation, Institut Pasteur, Paris, France.;INSERM U884, Paris, France. ^[4] Cardiovascular Institute and Department of Pediatrics, Stanford, CA. ^[5]

关键词 basic (laboratory) research/science calcineurin inhibitor: cyclosporine A (CsA)immunosuppressant lung transplantation/pulmonology rejection: acute rejection: vascular translational research/science vascular biology